首页> 外国专利> 3 - (3 - 4 - 4 - (4-morphine-2-il methyl - 2-oxo-2, 3-dihydro-1h-indol-5-il) methyl - 1, 3-thiophosphor-2, 4-dioxin and Tyr quinasa inhibitor of aldrin

3 - (3 - 4 - 4 - (4-morphine-2-il methyl - 2-oxo-2, 3-dihydro-1h-indol-5-il) methyl - 1, 3-thiophosphor-2, 4-dioxin and Tyr quinasa inhibitor of aldrin

机译:3-[(3-[4-[4-(4-吗啡-2-il]甲基]-2-oxo-2,3-dihydro-1h-吲哚-5-il)甲基]-1,3-硫代磷-2、4-二恶英和Tyr quinasa的艾氏剂抑制剂

摘要

It refers to 3 - [(3 - [4 - [4 - (4-morphine-methyl) - lh-pirrol-2-il] methyl] - 2-oxo-2, 3-dihydro-1h-indol-5-il] methyl] - 1, 3-tiazolidin-2, 4-diazo (I),Or its Z or e plasma and / or salts are addicted to acid or drug acceptable basis; and a thyroid hormone inhibitor of human epidemic growth factor (EGFR) receptor, namely geninib or erodinb. The association is very useful for the treatment of NSCLC, for patients with thyroid inhibitors of antigenic gastroenteritis.
机译:涉及3-[(3- [4-(4-(4-吗啡-甲基)-lh-吡咯-2-il]甲基]]-2-氧代2-,3-二氢-1h-吲哚-5- il]甲基]-1,3-噻唑烷-2,4-重氮(I),或其Z或e血浆和/或盐均以酸或药物可接受的基础上瘾;并且是人类流行性生长因子的甲状腺激素抑制剂( EGFR)受体,即geninib或erodinb。该联合对于治疗NSCLC,患有抗原性胃肠炎的甲状腺抑制剂的患者非常有用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号